International Academy of Cardiology Annual Scientific Sessions 2024 - 24th World Congress on Heart Disease

Topics

• DIAGNOSTIC METHODS
  • Transesophageal echocardiography
  • Biochemical markers of acute ischemia
  • Echocardiography, three-dimensional reconstruction
  • Pharmacologic stress testing - echocardiography
  • PET - new insights into myocardial metabolism
  • Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability
  • CT and coronary calcification
  • Applications of cardiac magnetic resonance imaging
  • Intravascular ultrasound imaging
  • Percutaneous coronary angioscopy
  • Intracoronary flow, doppler measurements
• MOLECULAR CARDIOLOGY, BASIC RESEARCH
  • Oxidative stress and anti-oxidant therapy
  • Apoptosis in vascular and cardiac remodeling
  • Genetic studies in cardiomyopathy
  • Genetic determinants of coronary heart disease
  • The pathogenesis of atherosclerosis
  • Gene transfer and therapy
  • Immunological principles in coronary artery disease
  • Extracellular matrix and atherosclerosis
  • Neointimal hyperplasia and vascular injury
  • Growth control and cytokines in vascular cells
  • Pharmacologic modulation of vascular-endothelial function
• HEART FAILURE
  • Nitric oxide and nitric oxide synthase in heart failure
  • Neurohumoral, immunologic and cytokine aspects of heart failure
  • Natriuretic peptides, endothelin: role in heart failure
  • Myocyte and receptor abnormalities in heart failure
  • Dilated cardiomyopathy: various etiologies
  • Inflammatory mediators and heart failure
  • Left ventricular hypertrophy and hypertrophic cardiomyopathy
  • Ischemic cardiomyopathy
  • Pathophysiologic and prognostic insights in valvular heart disease
  • Role of the pericardium, pericarditis and restrictive cardiomyopathy
  • Predictors and markers of heart failure outcome
  • Pulmonary circulation aspects, pulmonary hypertension
  • Renal aspects - diuretics
  • Exercise physiology in heart failure
  • ACE inhibitors and Angiotensin-ll receptor blockers
  • Digoxin and other new inotropic agents in heart failure
  • Calcium channel blockers and promoters in heart failure
  • Beta-blockers and beta-adrenergic receptors in heart failure
  • Cardiac pacing strategies in heart failure
• CORONARY ARTERY DISEASE
  • Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
  • The plaque and acute coronary syndromes
  • Angioplasty therapy for acute myocardial infarction
  • Acute myocardial infarction: thrombolysis and reperfusion
  • Antithrombotic and antiplatelet adjunctive therapy for PTCA
  • Stents: new devices/optimal application/multiple stents
  • Restenosis - use of ionizing radiation
  • Blockade of tissue proliferation after coronary interventions
  • Left ventricular remodeling after myocardial infarction
  • Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
  • Secondary prevention, risk stratification
  • Assessment of prognosis, post acute myocardial infarction
  • Can the progress of atherosclerosis be halted?
  • Cardiac rehabilitation as secondary prevention: is it worth the effort?
  • Hypertension, new therapeutic approaches
  • Modification of lipoproteins and coronary disease
  • Mental stress: its effect on cardiovascular health
  • Diabetes mellitus, obesity, insulin and atherosclerosis
  • Hormone therapy in postmenopausal women: does it alter coronary risk?
  • Primary prevention of coronary artery disease in the healthy adult
  • Prevention in children
• CARDIAC SURGERY
  • Angioplasty or surgery for multivessel coronary artery disease
  • Advances in congenital heart disease
  • Therapeutic and physiologic issues surrounding heart valve surgery
  • New approaches to surgical revascularization: Minimally invasive surgery, TMLR
  • Surgery for LV dysfunction
  • Mechanical support left ventricular assist devices
  • Cardiac transplantation
• ARRHYTHMIAS
  • Atrial flutter/fibrillation - electrophysiologic concepts and clinical aspects
  • Arrhythmias and antiarrhythmic drug therapy
  • Heart rate variability and prognostic implications
  • Management of cardiac arrhythmias pediatric population
  • Sudden death
  • QT prolongation/dispersion: pathophysiology and prognostic implications
  • Advances in internal defibrillation and implantable antiarrhythmic devices
  • Electrophysiologic techniques of mapping and radiofrequency ablation
  • Cardiac Pacing
• MISCELLANEOUS
  • Computers in cardiology
  • Practice guidelines, cost containment